Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rilpivirine Rollover Study for HIV-1
NCT01266902Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2011
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of rilpivirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Janssen Pharmaceutical. Started Feb 2011; status: completed.
02
Drugs
rilpivirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01266902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01266902.